苯并-1,2,3-噻二唑-5-羧酸 → N-(4-chloro-3-(pyridin-2-yl)phenyl)benzo[d][1,2,3]thiadiazole-5-carboxamide

HRID 922937

反应方程式

HRID 922937 反应方程式
[Cl:1][C:2]1[CH:8]=[CH:7][C:5]([NH2:6])=[CH:4][C:3]=1[C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][N:10]=1.[S:15]1[C:19]2[CH:20]=[CH:21][C:22]([C:24](O)=[O:25])=[CH:23][C:18]=2[N:17]=[N:16]1>>[Cl:1][C:2]1[CH:8]=[CH:7][C:5]([NH:6][C:24]([C:22]2[CH:21]=[CH:20][C:19]3[S:15][N:16]=[N:17][C:18]=3[CH:23]=2)=[O:25])=[CH:4][C:3]=1[C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][N:10]=1

参与物

3

反应物 2

HCID 2735458苯并-1,2,3-噻二唑-5-羧酸HCID 401519254-氯-3-(2-吡啶基)苯胺

产物 1

HCID 58614738N-(4-chloro-3-(pyridin-2-yl)phenyl)benzo[d][1,2,3]thiadiazole-5-carboxamide

实验过程

50 mg of 4-chloro-3-(pyridin-2-yl)aniline was coupled to benzo-1,2,3-thiadiazole-5-carboxylic acid via Procedure G. The crude product was purified via reverse phase HPLC to yield N-(4-chloro-3-(pyridin-2-yl)phenyl)benzo[d][1,2,3]thiadiazole-5-carboxamide. MS (Q1) 367 (M)+.

后处理

  1. customThe crude product was purified via reverse phase HPLC

来源与证据

ORD记录
ord-24b7fcfce10f4a0eb6922c5576869c72
来源数据集
uspto-grants-2016_03
专利号
US09278961B2

关联笔记

加载中…